MetaADEDB 2.0 @ LMMD
parecoxib
(TZRHLKRLEZJVIJ-UHFFFAOYSA-N)
Structure
SMILES
CCC(=O)NS(=O)(=O)c1ccc(cc1)c1c(C)onc1c1ccccc1
Type(s)
Approved
ATC code(s)
M01AH04
Molecular Formula:
C19H18N2O4S
Molecular Weight:
370.422
Log P:
5.0036
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
97.65
CAS Number(s):
198470-84-7
Synonym(s)
1.
parecoxib
2.
Dynastat
3.
N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamide
4.
N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, sodium salt
5.
N-(((Me-P)-P)S)P
6.
parecoxib sodium
External Link(s)
MeSHC409945
PubChem Compound119828
ChEBI73038
CHEMBLCHEMBL1206690
DrugBankDB08439
DrugCentral2063
IUPHAR/BPS Guide to PHARMACOLOGY2895
KEGGdr:D02709
dr:D03716
Therapeutic Target DatabaseD05UWI
ZINC5761797
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainSIDER
2Acute Coronary SyndromeSIDER
3AgitationSIDER
4Alanine Aminotransferase IncreasedSIDER
5Anaphylactic shockSIDER
6Anaphylactoid ReactionSIDER
7AngioedemaSIDER
8AnorexiaSIDER
9ArthralgiaSIDER
10Aspartate Aminotransferase IncreasedSIDER
11AstheniaSIDER
12Back PainSIDER
13Blood and lymphatic system disordersSIDER
14Blood creatine phosphokinase increasedSIDER
15Blood creatinine increasedSIDER
16Blood lactate dehydrogenase increasedSIDER
17Blood urea increasedSIDER
18BradycardiaSIDER
19BronchospasmSIDER
20ConstipationSIDER
21Creatine Phosphokinase IncreasedSIDER
22DermatitisSIDER
23DizzinessSIDER
24DyspepsiaSIDER
25Ear and labyrinth disordersSIDER
26EcchymosisSIDER
27Erythema MultiformeSIDER
28Fever15102535CTD
29FlatulenceSIDER
30Gastrointestinal PainSIDER
31Gastrointestinal sounds abnormalSIDER
32HepatitisSIDER
33HypersensitivitySIDER
34HypotensionSIDER
35InfectionSIDER
36InfestationSIDER
37Inflammation15102535CTD
38Injection Site ReactionSIDER
39Injection site painSIDER
40Lactic dehydrogenase activity increasedSIDER
41MalnutritionSIDER
42Musculoskeletal discomfortSIDER
43Myocardial InfarctionSIDER
44NauseaSIDER
45Nociceptive Pain23371449CTD
46OliguriaSIDER
47Pain19617648CTD
48PancreatitisSIDER
49PharyngitisSIDER
50Post procedural complicationSIDER
51PruritusSIDER
52Pulmonary EmbolismSIDER
53Reflex Sympathetic Dystrophy16115995CTD
54Respiratory FailureSIDER
55Respiratory InsufficiencySIDER
56ShockSIDER
57Stevens-Johnson SyndromeSIDER
58SwellingSIDER
59TachycardiaSIDER
60ThrombocytopeniaSIDER
61Toxic Epidermal NecrolysisSIDER
62UlcerSIDER
63UrticariaSIDER
64VomitingSIDER
65Wound InfectionSIDER
66nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.